Atlas Trials

National Cancer Center, China

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch National Cancer Center, China

RecordFirmDate
Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma (NCT07131345)National Cancer Center, China2025-09-01
Real-world Observational Study of Targeted Therapy in Patients With Advanced ROS1-positive NSCLC (NCT06694129)National Cancer Center, China2024-12-01
Combination of Vebreltinib and Osimertinib in Patients with EGFR 21 L858R Mutation Advanced NSCLC (NCT06827145)National Cancer Center, China2024-10-14
Surufatinib Combined With Tislelizumab in Advanced Lung Cancer With Neuroendocrine Differentiation (NCT06414915)National Cancer Center, China2024-06-01
A Study With BPI-1178 and Osimertinib in Advanced Non-small Cell Lung Cancer Patients With EGFR Mutations (NCT06362980)National Cancer Center, China2024-05-22
Laparoscopic Right Hemicolectomy With Transrectal Specimen Extraction for Colon Cancer (NCT06362902)National Cancer Center, China2024-03-01
Sentinel Lymph Node Biopsy in Rectal Cancer (NCT05830890)National Cancer Center, China2023-05-01
Lateral Pelvic Lymph Node Dissection for Rectal Neuroendocrine Neoplasms Undergoing Laparoscopic Total Mesenteric Excision (NCT06279299)National Cancer Center, China2022-08-01
The Role of Natural Orifice Specimen Extraction Surgery (NOSES) in Treating Right-sided Colon Cancer (NCT06753968)National Cancer Center, China2018-01-01
Mapping of Lymph Node Metastasis and Survival For pN+ Superficial Esophageal Squamous Cell Carcinoma (NCT05526456)National Cancer Center, China2012-02-01

Track National Cancer Center, China automatically

Every clearance here is in the API, with alerts when new ones post.